Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics


Amicus Therapeutics, Inc. (FOLD)

Today's Latest Price: $15.68 USD

0.13 (0.84%)

Updated Jul 2 10:40am

Add FOLD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

FOLD Stock Summary

  • Of note is the ratio of Amicus Therapeutics Inc's sales and general administrative expense to its total operating expenses; just 18.65% of US stocks have a lower such ratio.
  • FOLD's price/sales ratio is 18.62; that's higher than the P/S ratio of 92.34% of US stocks.
  • As for revenue growth, note that FOLD's revenue has grown 92.2% over the past 12 months; that beats the revenue growth of 93.83% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Amicus Therapeutics Inc, a group of peers worth examining would be STRO, BBIO, RMBS, CYTK, and ALBO.
  • FOLD's SEC filings can be seen here. And to visit Amicus Therapeutics Inc's official web site, go to www.amicusrx.com.
FOLD Daily Price Range
FOLD 52-Week Price Range

FOLD Stock Price Chart Technical Analysis Charts


FOLD Price/Volume Stats

Current price $15.68 52-week high $15.91
Prev. close $15.55 52-week low $6.25
Day low $15.54 Volume 213,542
Day high $15.81 Avg. volume 3,380,861
50-day MA $12.84 Dividend yield N/A
200-day MA $10.27 Market Cap 4.04B

Amicus Therapeutics, Inc. (FOLD) Company Bio


Amicus Therapeutics is developing treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.


FOLD Latest News Stream


Event/TimeNews Detail
Loading, please wait...

FOLD Latest Social Stream


Loading social stream, please wait...

View Full FOLD Social Stream

Latest FOLD News From Around the Web

Below are the latest news stories about Amicus Therapeutics Inc that investors may wish to consider to help them evaluate FOLD as an investment opportunity.

Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 8.9%

Amicus Therapeutics (FOLD) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Yahoo | June 22, 2020

Amicus Therapeutics: 2 Potential Blockbusters Make This Stock Worth Considering

Amicus Therapeutics (FOLD) is a commercial stage biopharma that is seeing huge sales growth of its one marketed product, Galafold, which treats Fabry disease. Sales of Galafold are expected to easily exceed $1 billion as are sales of Amicus' late-stage therapy for Pompe disease, AT-GAA. Despite this, Amicus currently has...

Andy Jones on Seeking Alpha | June 18, 2020

Amicus Therapeutics, Inc. (FOLD): Hedge Funds Folding Their Hands

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]

Yahoo | June 8, 2020

Why Is Amicus Therapeutics (FOLD) Up 10.9% Since Last Earnings Report?

Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Investment Research | June 6, 2020

Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

CRANBURY, N.J., June 04, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive…

GlobeNewswire | June 4, 2020

Read More 'FOLD' Stories Here

FOLD Price Returns

1-mo 19.33%
3-mo 68.06%
6-mo 70.81%
1-year 24.05%
3-year 55.56%
5-year 14.04%
YTD 60.99%
2019 1.67%
2018 -33.43%
2017 189.54%
2016 -48.76%
2015 16.59%

Continue Researching FOLD

Here are a few links from around the web to help you further your research on Amicus Therapeutics Inc's stock as an investment opportunity:

Amicus Therapeutics Inc (FOLD) Stock Price | Nasdaq
Amicus Therapeutics Inc (FOLD) Stock Quote, History and News - Yahoo Finance
Amicus Therapeutics Inc (FOLD) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.936 seconds.